Market revenue in 2020 | USD 6,044.5 million |
Market revenue in 2028 | USD 10,635.8 million |
Growth rate | 7.3% (CAGR from 2020 to 2028) |
Largest segment | Injectable |
Fastest growing segment | Oral |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
Key market players worldwide | Pfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Injectable was the largest segment with a revenue share of 63.9% in 2020. Horizon Databook has segmented the North America atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
North America is the largest revenue-generating region in the market, owing to a high level of awareness among the population regarding skin diseases such as atopic dermatitis. The market is further propelled by the local presence of major market players, developed healthcare infrastructure, and increasing prevalence of atopic dermatitis.
There has been an increase in number of strategic partnerships between major pharmaceuticals companies looking to develop atopic dermatitis drugs. This is improving the status of pipeline products. The COVID-19 pandemic is expected to positively impact market growth.
This can be attributed to increased frequency of handwashing by the population adhering to safety and sanitation measures, which helps prevent the spread of SARS-CoV-2. However, constant exposure to soap and water has increased dry skin, leading to an increase in cases of hand atopic dermatitis.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America atopic dermatitis drugs market , including forecasts for subscribers. This continent databook contains high-level insights into North America atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account